View in EDS

Patient-reported outcomes in castration-resistant prostate cancer with bone metastases treated with radium-223 with or without olaparib.

Saved in:
Bibliographic Details
Title: Patient-reported outcomes in castration-resistant prostate cancer with bone metastases treated with radium-223 with or without olaparib.
Authors: McKay RR; Division of Medical Oncology, Department of Medicine, University of California San Diego, La Jolla, California, USA.; Department of Urology, University of California San Diego, La Jolla, California, USA.; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, USA., Xie W; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Ajmera A; Division of Medical Oncology, Department of Medicine, University of California San Diego, La Jolla, California, USA., Araneta A; Division of Medical Oncology, Department of Medicine, University of California San Diego, La Jolla, California, USA., Folefac E; Department of Internal Medicine, Ohio State University, Columbus, Ohio, USA., Hussain A; Department of Medicine, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA., Kyriakopoulos CE; Division of Hematology, Medical Oncology, and Palliative Care, Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA., Olson A; Department of Radiation Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Parikh M; Division of Hematology and Oncology, Department of Internal Medicine, University of California Davis, Sacramento, California, USA., Parikh R; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA., Saraiya B; Division of Medical Oncology, Department of Medicine, Rutgers Robert Wood Johnson Medical School and Rutgers Cancer Institute, New Brunswick, New Jersey, USA., Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Source: Cancer [Cancer] 2026 Jul 01; Vol. 132 (13), pp. e70496.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42319132
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Patient-reported outcomes in castration-resistant prostate cancer with bone metastases treated with radium-223 with or without olaparib.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22McKay+RR%22">McKay RR</searchLink>; Division of Medical Oncology, Department of Medicine, University of California San Diego, La Jolla, California, USA.; Department of Urology, University of California San Diego, La Jolla, California, USA.; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, USA.<br /><searchLink fieldCode="AU" term="%22Xie+W%22">Xie W</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Ajmera+A%22">Ajmera A</searchLink>; Division of Medical Oncology, Department of Medicine, University of California San Diego, La Jolla, California, USA.<br /><searchLink fieldCode="AU" term="%22Araneta+A%22">Araneta A</searchLink>; Division of Medical Oncology, Department of Medicine, University of California San Diego, La Jolla, California, USA.<br /><searchLink fieldCode="AU" term="%22Folefac+E%22">Folefac E</searchLink>; Department of Internal Medicine, Ohio State University, Columbus, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Hussain+A%22">Hussain A</searchLink>; Department of Medicine, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Kyriakopoulos+CE%22">Kyriakopoulos CE</searchLink>; Division of Hematology, Medical Oncology, and Palliative Care, Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.<br /><searchLink fieldCode="AU" term="%22Olson+A%22">Olson A</searchLink>; Department of Radiation Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Parikh+M%22">Parikh M</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, University of California Davis, Sacramento, California, USA.<br /><searchLink fieldCode="AU" term="%22Parikh+R%22">Parikh R</searchLink>; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Saraiya+B%22">Saraiya B</searchLink>; Division of Medical Oncology, Department of Medicine, Rutgers Robert Wood Johnson Medical School and Rutgers Cancer Institute, New Brunswick, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Shapiro+GI%22">Shapiro GI</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220374236%22">Cancer</searchLink> [Cancer] 2026 Jul 01; Vol. 132 (13), pp. e70496.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0374236 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0142 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220008543X%22">0008543X </searchLink><i>NLM ISO Abbreviation: </i>Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42319132
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cncr.70496
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70496
    Titles:
      – TitleFull: Patient-reported outcomes in castration-resistant prostate cancer with bone metastases treated with radium-223 with or without olaparib.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: McKay RR
      – PersonEntity:
          Name:
            NameFull: Xie W
      – PersonEntity:
          Name:
            NameFull: Ajmera A
      – PersonEntity:
          Name:
            NameFull: Araneta A
      – PersonEntity:
          Name:
            NameFull: Folefac E
      – PersonEntity:
          Name:
            NameFull: Hussain A
      – PersonEntity:
          Name:
            NameFull: Kyriakopoulos CE
      – PersonEntity:
          Name:
            NameFull: Olson A
      – PersonEntity:
          Name:
            NameFull: Parikh M
      – PersonEntity:
          Name:
            NameFull: Parikh R
      – PersonEntity:
          Name:
            NameFull: Saraiya B
      – PersonEntity:
          Name:
            NameFull: Shapiro GI
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1097-0142
          Numbering:
            – Type: volume
              Value: 132
            – Type: issue
              Value: 13
          Titles:
            – TitleFull: Cancer
              Type: main
ResultId 1